Company: VERA
Filing Date: 2025-12-10
Form Type: 424B5
Source: 0001193125-25-314244
Chunk: 24

Company: Vera Therapeutics, Inc.
Filing Date: 2025-12-10
Form: 424B5
Chunk 24
---
 demand for, or exercise any right with respect to, the registration of any lock-up securities except for a registration statement on Form S-8, or
(4) publicly disclose the intention to do any of the foregoing. Such persons or entities have further acknowledged that these undertakings preclude them from engaging in any hedging or other transactions or arrangements (including, without
limitation, any short sale or the purchase or sale of, or entry into, any put or call option, or combination thereof, forward, swap or any other derivative transaction or instrument, however described or defined) designed or intended, or which could
reasonably be expected to lead to or result in, a sale or disposition or transfer (by any person or entity, whether or not a signatory to such agreement) of any economic consequences of ownership, in whole or in part, directly or indirectly, of any lock-up securities, whether any such transaction or arrangement (or instrument provided for thereunder) would be settled by delivery of lock-up securities, in cash or
otherwise.

The restrictions described in the immediately preceding paragraph and contained in the lock-up agreements between
the underwriters and the lock-up parties do not apply, subject in certain cases to various conditions, to certain transactions, including, but not limited to: (i) transactions, transfers, sales or
dispositions of, or entering into any other transactions (including any swap) relating to the lock-up securities acquired in this offering or in the open market or other transactions after the completion of
this offering, or that otherwise do not involve or relate to securities owned by the lock-up parties prior to this offering, provided that no filing under the Exchange Act or other public disclosure shall be
required or shall be voluntarily made during the restricted period in connection with subsequent sales of shares of common stock or other securities acquired in such open market transactions during the restricted period, other than any required
filing under Section 13 of the Exchange Act; (ii) transfers of lock-up securities by gift, including, without limitation, to a charitable organization, or by will or intestate succession to the legal
representative, heir or beneficiary of the lock-up party or any family member, or to a trust whose beneficiaries consist exclusively of one or more of the lock-up party
and/or a family member; (iii) transfers or dispositions of the lock-up securities to a corporation, partnership, limited liability company or other entity, all of the beneficial ownership interests of
which, in each case, are held